Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

Journal: Cell

Published: 2020-10-29

DOI: 10.1016/j.cell.2020.09.015

Affiliations: 24

Authors: 36

Go to article
Institutions Share
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.27
Sage Bionetworks, United States of America (USA) 0.13
University of California, Los Angeles (UCLA), United States of America (USA) 0.11
Washington University in St. Louis (WUSTL), United States of America (USA) 0.08
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.06
Oncode Institute, Netherlands 0.06
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.05
Institute for Systems Biology (ISB), United States of America (USA) 0.04
Cancer Research Institute (CRI), United States of America (USA) 0.04
La Jolla Institute for Immunology (LJI), United States of America (USA) 0.03
California Institute of Technology (Caltech), United States of America (USA) 0.03
Cornell University, United States of America (USA) 0.02
University of Pennsylvania (Penn), United States of America (USA) 0.01
University of Washington (UW), United States of America (USA) 0.01
Broad Institute of MIT and Harvard, United States of America (USA) 0.01
Massachusetts General Hospital (MGH), United States of America (USA) 0.01
University of California, San Diego (UC San Diego), United States of America (USA) 0.01
Netherlands Cancer Institute (NKI), Netherlands 0.01
BioNTech US, United States of America (USA) 0.01

Return